Literature DB >> 3022137

Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells.

B Zerler, B Moran, K Maruyama, J Moomaw, T Grodzicker, H E Ruley.   

Abstract

Plasmids expressing partial adenovirus early region 1A (E1A) coding sequences were tested for activities which facilitate in vitro establishment (immortalization) of primary baby rat kidney cells and which enable the T24 Harvey ras-related oncogene and the polyomavirus middle T antigen (pmt) gene to transform primary baby rat kidney cells. E1A cDNAs expressing the 289- and 243-amino acid proteins expressed both E1A transforming functions. Mutant hrA, which encodes a 140-amino acid protein derived from the amino-terminal domain shared by the 289- and 243-amino acid proteins, enabled ras (but not pmt) to transform and facilitated in vitro establishment to a low, but detectable, extent. These studies suggest that E1A functions which collaborate with ras oncogenes and those which facilitate establishment are linked. Furthermore, E1A transforming functions are not associated with activities of the 289-amino acid E1A proteins required for efficient transcriptional activation of viral early region promoters.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022137      PMCID: PMC367589          DOI: 10.1128/mcb.6.3.887-899.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Adenovirus E1a proteins repress transcription from the SV40 early promoter.

Authors:  A Velcich; E Ziff
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

2.  Evidence that a second tumor antigen coded by adenovirus early gene region E1a is required for efficient cell transformation.

Authors:  D R Hurwitz; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products.

Authors:  K P Haley; J Overhauser; L E Babiss; H S Ginsberg; N C Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

4.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.

Authors:  D Eliyahu; A Raz; P Gruss; D Givol; M Oren
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

5.  Isolation of type 5 adenovirus mutants with a cold-sensitive host range phenotype: genetic evidence of an adenovirus transformation maintenance function.

Authors:  Y S Ho; R Galos; J Williams
Journal:  Virology       Date:  1982-10-15       Impact factor: 3.616

6.  Regulation of heat shock protein 70 gene expression by c-myc.

Authors:  R E Kingston; A S Baldwin; P A Sharp
Journal:  Nature       Date:  1984 Nov 15-21       Impact factor: 49.962

7.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.

Authors:  J R Jenkins; K Rudge; G A Currie
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

8.  Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription.

Authors:  E Borrelli; R Hen; P Chambon
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Dissection of overlapping functions within the adenovirus type 5 E1A gene.

Authors:  G Winberg; T Shenk
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  86 in total

1.  Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.

Authors:  D C Barnard; J G Patton
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Adenovirus E1A makes two distinct contacts with the retinoblastoma protein.

Authors:  N Dyson; P Guida; C McCall; E Harlow
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Upstream DNA sequences determine different autoregulatory responses of the adenovirus types 5 and 3 E1A promoters.

Authors:  S N Jones; C Tibbetts
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

Review 4.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

5.  Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins.

Authors:  E White; R Cipriani; P Sabbatini; A Denton
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

6.  Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation.

Authors:  U Schaeper; J M Boyd; S Verma; E Uhlmann; T Subramanian; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products.

Authors:  P Yaciuk; M C Carter; J M Pipas; E Moran
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

9.  Regulation of alternative splicing by SRrp86 and its interacting proteins.

Authors:  Jun Li; Ian C Hawkins; Christopher D Harvey; Jennifer L Jennings; Andrew J Link; James G Patton
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors.

Authors:  Jessica Komorek; Mohan Kuppuswamy; T Subramanian; S Vijayalingam; Elena Lomonosova; Ling-Jun Zhao; Joe S Mymryk; Kimberly Schmitt; G Chinnadurai
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.